JULIE GEDALECIA: Open Payments
NPI 1063069748 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 66 payments from 20 companies in 2025. Trend: 2023 $1,403 · 2024 $1,116 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 21 | $175 |
| GlaxoSmithKline, LLC. | 9 | $174 |
| Lilly USA, LLC | 6 | $152 |
| Indivior Inc. | 4 | $128 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Amgen Inc. | 3 | $63 |
| Lundbeck LLC | 2 | $60 |
| Novo Nordisk Inc | 2 | $59 |
| ABBVIE INC. | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
Products named: Kerendia, TRELEGY ELLIPTA, JARDIANCE, SUBLOCADE, REXULTI, Wegovy, MOUNJARO, FARXIGA.
Industry payments across CT — which companies pay providers there.
